During the past decade, Cancer Therapy and Integrative Medicine conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 55 clinical trials were completed, i.e. on average, 88.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 45 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Therapy and Integrative Medicine" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Children's Oncology Group" with 6 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Therapy and Integrative Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Therapy and Integrative Medicine" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (5 trials), "Breast Cancer" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Cancer Therapy and Integrative Medicine" in a lesser frequency.

Most popular intervention types in "Cancer Therapy and Integrative Medicine" are "Drug" (80 trials), "Other" (77 trials), "Biological" (36 trials), "Procedure" (17 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (22 trials), "Carboplatin" (11 trials), "Nivolumab" (11 trials) and "Cisplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Therapy and Integrative Medicine" are 83 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Therapy and Integrative Medicine". undefined are not yet recruiting, 9 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Cancer Therapy and Integrative Medicine, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Therapy and Integrative Medicine, 2 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".